Next Article in Journal
Two New Oleanane-Type Saponins with Anti-Proliferative Activity from Camellia oleifera Abel. Seed Cake
Next Article in Special Issue
The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells
Previous Article in Journal
Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
 
 
Article

Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux

1
Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
2
Tianjin International Joint Academy of Biomedicine, Tianjin 300457, China
*
Author to whom correspondence should be addressed.
Academic Editor: Helena Vasconcelos
Molecules 2016, 21(2), 183; https://doi.org/10.3390/molecules21020183
Received: 30 November 2015 / Revised: 26 January 2016 / Accepted: 28 January 2016 / Published: 4 February 2016
(This article belongs to the Special Issue New Approaches to Counteract Drug Resistance in Cancer)
Multidrug resistance (MDR) is a prime reason for numerous failed oncotherapy approaches. In the present study, we investigated whether Alisol F 24 acetate (ALI) could reverse the MDR of MCF-7/DOX cells, a multidrug-resistant human breast cancer cell line. We found that ALI was a potent P-glycoprotein (P-gp) inhibitor, in the Caco-2-monolayer cell model. ALI showed a significant and concentration-dependent cytotoxic effect on MCF-7/DOX cells in combination with doxorubicin by increasing intracellular accumulation and inducing nuclear migration of doxorubicin. However, ALI had no such effect on MCF-7 cells. In addition, ALI also promoted doxorubicin-induced early apoptosis of MCF-7/DOX cells in a time-dependent manner. These results suggest that ALI can enhance chemosensitivity of doxorubicin and reinforce its anti-cancer effect by increasing its uptake, especially inducing its nuclear accumulation in MCF-7/DOX cells. Therefore, ALI could be developed as a potential MDR-reversing agent in cancer chemotherapy in further study. View Full-Text
Keywords: alisol F 24-acetate (ALI); multidrug resistance (MDR); doxorubicin; P-glycoprotein (P-gp) alisol F 24-acetate (ALI); multidrug resistance (MDR); doxorubicin; P-glycoprotein (P-gp)
Show Figures

Graphical abstract

MDPI and ACS Style

Pan, G.; Li, T.; Zeng, Q.; Wang, X.; Zhu, Y. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux. Molecules 2016, 21, 183. https://doi.org/10.3390/molecules21020183

AMA Style

Pan G, Li T, Zeng Q, Wang X, Zhu Y. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux. Molecules. 2016; 21(2):183. https://doi.org/10.3390/molecules21020183

Chicago/Turabian Style

Pan, Guixiang, Tingting Li, Qingqing Zeng, Xiaoming Wang, and Yan Zhu. 2016. "Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux" Molecules 21, no. 2: 183. https://doi.org/10.3390/molecules21020183

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop